
|Articles|June 1, 2002
Terbinafine shows dose-dependency in tinea capitis
New Orleans - Dose rather than duration of therapy appears to be the important factor for achieving favorable cure rates using oral terbinafine (Lamisil) for the treatment of tinea capitis, Sheila Fallon Friedlander, M.D., said at the annual meeting of the American Academy of Dermatology.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Global Hidradenitis Suppurativa Atlas (GHiSA) Finds HS Affects 1% of the World's Population
2
Delgocitinib Offers Targeted Relief for the Painful Burden of Chronic Hand Eczema
3
When Hives Do Not Quit: A Practical Update on Chronic Spontaneous Urticaria
4
Top 5 Articles of the Week: December 7-12
5


















